Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk - sprookjes - yvandenbroek - TriplyDB

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

http://www.wikidata.org/entity/Q33905119

about

The epidemiology of sarcoma Li-fraumeni syndrome A census of human cancer genes Genetic causes of cancer predisposition in children and adolescents An information-theoretic analysis of genetics, gender and age in cancer patients Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.Single-nucleotide polymorphisms in the p53 signaling pathway.Effects of measured susceptibility genes on cancer risk in family studies.Evaluation of a decision aid for families considering p53 genetic counseling and testing.Detection of functional single-nucleotide polymorphisms that affect apoptosis Clinical management of hereditary breast cancer syndromes.Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.Small-area analyses of bone cancer diagnosed in Great Britain provide clues to aetiology.Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.10 rare tumors that warrant a genetics referral.Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.Prevalence of germline TP53 mutations in HER2+ breast cancer patients.Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck Germline TP53 mutational spectrum in French Canadians with breast cancer.Epidemiology and genetics of childhood cancer.Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.Gene-panel sequencing and the prediction of breast-cancer risk.Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.Germline TP53 variants and susceptibility to osteosarcoma.p53 and disease: when the guardian angel fails.Timing and context: important considerations in the return of genetic results to research participants.Early onset HER2-positive breast cancer is associated with germline TP53 mutations.Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.Type I natural killer T cells suppress tumors caused by p53 loss in mice.Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.Common breast cancer risk variants in the post-COGS era: a comprehensive review.Diagnostic cancer genome sequencing and the contribution of germline variants.Syndrome-associated soft tissue tumours.Li-Fraumeni syndrome: cancer risk assessment and clinical management.

P2860

Q21195878-18199878-7B68-4330-867B-CD95337B17F2 Q22241780-ADF7E4DF-259D-4827-BE4A-963E962EF28D Q24647081-FB4106CC-0E69-4723-8FE7-CFCF9BA067B1 Q26770339-BFEA2E6E-DF38-4D99-8F7C-B9FFB920B577 Q33327370-71E5E06E-8965-4250-AF31-0428636E8D67 Q33593066-3FB0546C-AC18-4DD0-AAEC-AE15F0FF720D Q33800384-C98EFF1B-F496-4DD9-86DA-952679048A14 Q34052361-12AE4688-050E-4150-AD5E-DEE380DDB001 Q34093171-92734AA1-6426-4FD3-843A-28587C645B84 Q34132497-64316AE7-BD48-41E9-8F75-143F194196EF Q34167563-7A61BCB2-129C-4024-B270-4D63391B1901 Q34294432-F66C294D-080B-4B1A-A2CD-FCD7CFEB7D8E Q34306492-1E55948B-A4E6-4F51-9936-B39EA8DFA9BE Q34318891-AC555F2E-1479-40BA-95A1-23CF4045D775 Q34324382-061E6229-310E-4904-810C-1D9895E4B288 Q34324683-F8E1FC13-DF01-4225-A029-5E53D49F578E Q34325954-D4A9A80D-3389-4186-B494-C53BA2A0BB74 Q34631589-A8C737DC-E0D0-4396-9691-B2B3196572BD Q34789542-9987F4E7-04D5-4001-AA82-480C432DC660 Q34915251-4361B410-A4EA-401C-A7C9-B9A0767FCB1B Q35205646-B7B6A11E-52E2-4631-A2F8-E2F2D498F0D4 Q35448964-60D21002-410D-4EEC-8B49-BB006E6285D4 Q35618321-BAE58581-5ABE-49B7-850B-6B45D689A687 Q35868038-6C0F0779-79DF-4209-8D4A-01E2BB0B57B1 Q35896015-6E98358F-BE9E-43CE-A5B1-033758159C2E Q36175072-3DB76A48-B31C-48C0-ACD5-ECDB5B3EBF29 Q36245632-A06CEC39-F1FC-4BE0-B5E2-176EB5C54010 Q36294747-7974C7DB-9A16-46E1-8E39-B5F98251006B Q36430165-B9D14AAD-4FE4-4AE5-BBCB-DD10D497B108 Q36470928-09B169A6-4DC2-4117-AB82-40AD88394BEA Q36481648-256063E9-FD81-414F-97A8-8B30B71FEE07 Q36672536-CB0F5BA9-F647-4253-BB19-2B9B8ACFDAD4 Q36843211-1E642779-8274-49B0-89EF-CC6FB8B0ABD3 Q37006537-69B4533A-3AEF-4E1C-BD3F-A2B6E289D142 Q37262415-ED4BFB11-7D63-4D5B-A0E9-FBC6D747D354 Q37368251-F281E6E3-1856-48C1-A04B-C8162704C94F Q37690575-BAA5240C-4BC4-4FD3-96A2-241D90746BB1 Q38094131-691C19F4-7B4F-4EF4-9694-43D935B6BC3E Q38162895-9FFEA31F-4784-4E03-9C44-18B7F3096AAD Q38197030-01F7369B-6E66-4336-B08E-3D8CBB46BDC7

P2860

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

http://www.wikidata.org/entity/Q33905119

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@ast

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@en

type

label

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@ast

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@en

prefLabel

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@ast

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@en

P1433

Q33905119-B2F0CE2C-CE95-4F93-A21D-CD7025A6D08E

P1476

Q33905119-786DC9FD-A8C6-4E62-BBD5-079F52812D36

P2093

Q33905119-34B9C4CC-251E-4C37-9AC9-D02E91E2E7B4

Q33905119-75D10923-284B-4108-A684-89DE0CBD9965

Q33905119-9B1A843E-678D-4552-AA36-682BA72BD281

P2860

Q33905119-0001D999-8745-43A3-AFAB-5789FC8BC0A1

Q33905119-00866678-2B58-454A-B36B-303AFF5E39F3

Q33905119-083B459B-3965-4B1B-BB7F-2A4F0847C7BD

Q33905119-106533B3-08BF-4A9E-9F38-C193E646CB11

Q33905119-1BA4E9B9-AF6E-46C7-96A0-FEBF1C57C096

Q33905119-1CB42E2B-EBAD-48B8-B60D-2749431B1C39

Q33905119-243863E8-95D2-44DE-B283-7FBF01152A4C

Q33905119-259F67B6-267D-49AA-8F1F-30A665E2F75F

Q33905119-29A9648A-5863-483C-89E8-CC49B2EEE16D

Q33905119-2A26D615-9522-42A2-BC47-2D497C302F88

P304

Q33905119-1B7377F4-CC32-4E6E-B566-298041E5E376

P31

Q33905119-38B7CBE1-D0F9-4598-BFD4-D6CCE045EDA0

P356

Q33905119-1E76FD4C-98E4-4F6D-9AB2-BF0F25B7951E

P407

Q33905119-95A8B270-958D-4BEA-A408-17062231D213

P433

Q33905119-CD8DD26F-8954-495C-BD56-C9A9F73E0F68

P478

Q33905119-6D945434-B6D3-4968-8B35-F1DE0BE343AB

P50

Q33905119-9376C4F9-A3F4-47C4-830D-9B7EAC1DB9A4

P577

Q33905119-7F8BC397-3456-4C85-B05E-0D95C420B0E0

P5875

Q33905119-6554E621-068C-468D-AD26-126AD8E69A2E

P698

Q33905119-AA854EFA-58B4-416D-8271-5B1740F57F87

P932

Q33905119-7BCC8F8E-25E4-4C94-813B-2FA78E1727F4

P356

P1433

American Journal of Human Genetics

P1476

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

@en

P2093

Guillermina Lozano

http://www.w3.org/2001/XMLSchema#string

Louise C Strong

http://www.w3.org/2001/XMLSchema#string

Shih-Jen Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

p53, the cellular gatekeeper for growth and division

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.

IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.

Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.

p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.

Gain of function properties of mutant p53 proteins at the mitotic spindle cell cycle checkpoint.

Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

Gain-of-function mutations in the tumor suppressor gene p53.

p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect.

P304

975-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/374567

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Amos

P577

2003-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10878832

http://www.w3.org/2001/XMLSchema#string

P698

12610779

http://www.w3.org/2001/XMLSchema#string

P932

1180359

http://www.w3.org/2001/XMLSchema#string